Lung cancer is the leading cause of cancer deaths all across the world. It accounts for about 1.8m deaths every year. Doctors have begun trailing the world’s first lung cancer vaccine mRNA…
Tag: Treatment Options For Lung Cancer
Osimertinib Plus Chemo Approved as Ist-Line Treatment for Patients with Lung Cancer
Lung cancer is the leading cause of cancer deaths among both men and women. It broadly splits into NSCLC and small cell lung cancer. Osimertinib (Tagrisso) in combination with pemetrexed and platinum-containing…
Researchers Find How Precision Radiation Therapy Supports In Lung Cancer Treatment
A recent study has been conducted by the researchers at The University of Texas MD Anderson Cancer Centre and the results of which were published in JAMA Oncology. According to this study,…
FDA Grants Approval to Amgen’s Treatment for deadly form of Lung Cancer
Every year, about 35k Americans are diagnosed with small cell lung cancer and the cancer usually has spread beyong the lung by the time it gets detected. The Food and Drug Administration…
An Overview of Platinum-based Chemotherapy for Lung Cancer
Chemotherapy is one of the most common forms of cancers treatments. The medication aims at destroying cancer cells. Platinum-based chemotherapy drugs are used to treat various cancer types such as lung, breast,…
Roche’s Genentech Gets FDA Approval for Lung Cancer Treatment
Genetech, a member of the Roche Group, had announced that U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment of patients with early stage, anaplastiv lymphoma kinase-positive non-small…
New Deep Learning Tool To Predict Brain Metastasis In Lung Cancer Patients
Lung cancer is the leading cause of deaths from cancers worldwide. Most lung cancers are characterized as non-small cell lung cancer and about 30% of patients progress to advanced stages when it…
Gene Signature to Help Patients with NSCLC
Lung cancer is the leading cause of cancer mortality in the United States and all across the world. Non-small cell lung cancer (NSCLC) accounts for about 80 to 85% of all lung…
SABR For Inoperable Early Stage NSCLC
Stereotactic Ablative Radiotherapy (SABR) is an external beam treatment modality that delivers high precision large doses of radiation. In simple words, it is a way of giving Radiotherapy to precisely target cancer…
Combination Of Radiation And Immunotherapy For Advanced Non-Small Cell Lung Cancer
According to the new study by researchers from the UCLA Health Jonsson Comprehensive Cancer Center, using high doses of radiation with an ablative radiotherapy technique is effective for treatment with locally advanced…
New Study Finds A Way To Stop Key Lung Cancer Spread Protein
Lung cancer is among the most common types of cancers prevailing all over the world. A new study by Tulane University has found a molecular pathway to stop lung cancer spread. The…
Durvalumab for Treatment of Lung Cancer
Durvalumab is a type of immunotherapy and is known by its brand name, Imfinzi. Its role in treatment of small cell lung cancer is increasing. Durvalumab injection is injected into a vein…